NCT03606291View on ClinicalTrials.gov

NSCLC Isotoxic Hypofractionated Radiotherapy

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2026

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
RADIATION

isotoxic hypofractionation

the normal tissue limits are uniform, such as: V20% ≤ 30%, spinal cord 0\> 45Gy, etc., and used hypofractionated radiotherapy technology so that each patient received the maximum individualized radiation dose as possible

Trial Locations (1)

050000

RECRUITING

The Second Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

The Second Hospital of Hebei Medical University

OTHER